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Accuracy of clinical diagnosis for the 
identification of potentially malignant 
disorders and malignant lip lesions
Abstract: The aim of this study was to assess the accuracy of clinical 
diagnosis for lip lesions based on sensitivity and specificity. The 
retrospective analysis focused on the detection of lesions caused 
by potentially malignant disorders (PMDs) and malignant lesions 
(n = 1195). All cases were classified as benign, PMD, and malignant 
lesions. Concordance between diagnoses based on clinical examination 
and those based on histopathological analysis was assessed, and 
accuracy for the identification of PMD and malignant lesions was 
calculated. Histopathological analysis revealed 44 lesion types; 
PMD and malignant lesions comprised 8.3% of all cases. Compared 
with histopathological analysis, clinical examination showed 97.4% 
accuracy for the identification of non-malignant and potentially 
malignant/malignant cases. Degrees of specific sensitivity ranged from 
34% to 77% for different lesions, and were highest for autoimmune 
(77%) and reactive (72%) lesions. Positive and negative predictive 
values for the identification of PMD and malignant lesions were 81.9% 
and 98.9%, respectively. Clinical examination showed a high degree of 
accuracy for the detection of PMD and malignant lip lesions, indicating 
good reliability.
Keywords: lip disease; clinical diagnosis; neoplasm.
Introduction
The burden of oral and nasopharyngeal cancer is importunate, as more 
than 48,000 new cases and 9,500 deaths are estimated to occur in the US 
alone in 2016.1 In 2012, an estimated 387,000 new cases and more than 
196,000 deaths due to this cancer occurred worldwide.2 Between 1979 and 
2002, more than 78,000 deaths due to oral and nasopharyngeal cancer were 
recorded in Brazil.3 The average 5-year survival rate for cancer at these 
sites is 63.2%.4,5,6 This estimate has increased over the past few decades, 
and ranges from 37% and 83%, depending on location and stage at the 
time of diagnosis.6
Due to their anatomic location, the lips are exposed to a variety of 
irritants and carcinogenic agents; factors such as ultraviolet (UV) radiation, 
tobacco, food, and trauma can alter the normal tissue integrity.7,8,9 In addition, 
the lips form a transitional zone between the mucosal tissues and the 
skin; thus, the characteristics of lip cancer differ from those of other oral 
cavity and nasopharyngeal malignancies. In 2010, 6% of all new cases 
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of cancer in the oral cavity and pharynx in the UK 
were located in the lips.10 Although this form of the 
disease is associated with favorable 5-year survival 
rates, ranging from 52% to 93%,10,11 the early diagnosis 
of such cases is of concern.12,13 The reported prevalence 
of malignancy among lip lesions ranges from 12% to 
21%.14,15 In addition, despite the favorable survival rates 
for lip cancer, the consequences of surgical resection 
are important factors that can impair quality of life.16
Conventional clinical oral examination has long 
been the standard method for the assessment of 
oral lesions, including those caused by potentially 
malignant disorders (PMDs), and for oral cancer 
screening.17,18 Clinical evaluation of the lip region is 
facilitated by the anatomic location. However, oral 
examination alone is not sufficient for the detection 
and accurate distinction of benign, PMD, and 
malignant lesions.19,20 Clinical screening followed 
by histopathological analysis is crucial, given the 
estimated annual number of new lip cancer cases 
worldwide and the wide range of lesions that occur 
in this location.21,22 Biopsy, paired with clinical 
examination, is recommended for final diagnosis; 
in addition, this approach is recommended when 
lesions persist despite treatment or the removal of local 
irritants (of traumatic or inflammatory origin), when 
lesions do not recede in 2 weeks, when malignancy is 
suspected, and when lesions interfere with function 
or impair aesthetics.23
The rate of concordance between clinical and 
histopathological diagnoses of oral lesions ranges 
from 36% to 50%.24,25,26,27 In contrast, a few studies have 
reported high degrees of sensitivity and specificity, 
and high positive predictive value, of clinical oral 
examination for the detection of malignancies,28,29,30 
indicating that the initial clinical evaluation is reliable 
for the early detection of malignant and PMD lesions. 
More importantly, clinicians’ decision making 
following such examination can be supported by 
knowledge of diagnostic accuracy. To our knowledge, 
no study has assessed the diagnostic accuracy and 
predictive value of PMDs and malignant lesions with 
a focus on the lip region.
The aim of this study was to determine the 
diagnostic accuracy of lip lesions in a retrospective 
analysis of clinical and histopathological aspects and 
distribution of lip lesions in a large sample of patients.
Methodology
Study design and sample
This retrospective study was conducted using 
data from the Department of Oral Pathology of the 
School of Dentistry, Federal University of Rio Grande 
do Sul (UFRGS), Porto Alegre, Brazil. Private and 
public dentists, and predominantly undergraduate 
and graduate students of the institution, submit 
specimens to the laboratory for histopathological 
examination. In addition, the laboratory receives 
samples obtained for research purposes via 
experimental studies conducted at the school. Data 
on lip biopsy specimens recorded between 1946 
and 2011 were retrieved from the laboratory. Data 
on patients’ demographic characteristics (sex, age, 
and ethnicity), clinical data (location and diagnostic 
hypothesis), and histopathological (final) diagnoses 
were collected.
Outcome classification
Self-reported ethnicity was classified using the 
terms “white,” “brown,” and “black.” The location 
of lip lesions was classified as lower lip, upper lip, 
commissure, and not specified. Lesions located on 
the internal parts of the lips were also included. 
For clinical and histopathological diagnoses, 
lesions were divided into seven groups: disorders 
of epithelial maturation (G1), autoimmune lesions 
(G2), reactive lesions (G3), infectious lesions (G4), 
benign neoplasms (G5), malignant neoplasms (G6), 
and other (G7). For further analyses, all lesions 
were divided into three groups: benign (G1–G5, 
G7), PMD (part of G1), and malignant (G6). More 
specifically, lesions with histopathological diagnoses 
of actinic cheilitis and cases of epithelial dysplasia 
(initially assigned to G1) were placed in the PMD 
group.31 The final outcome classification was based 
on histopathological diagnoses.
Statistical analysis
Data were analyzed using the Statistical Package 
for the Social Sciences (SPSS; version 20 for Macintosh; 
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SPSS Inc., Chicago, USA). The individual was used as 
the unit of analysis, and the significance level was set 
at 5%. Demographic, clinical, and histopathological 
data were evaluated by the sensitivity test and Fisher’s 
exact test. Diagnostic accuracy was calculated based 
on the sensitivity, specificity, likelihood ratio, and 
predictive value; the final classification of diagnoses 
(benign, potentially malignant, and malignant) was 
used for this assessment. The cutoff values used to 
interpret sensitivity were >80% (excellent), 70–80% 
(good), 60–69% (fair), and <60% (poor); those used 
for specificity were >90% (excellent), 80–90% (good), 
70–79% (fair), and <70% (poor).32
Ethical approval
The use of human subject data followed the 
ethical requirements of, and was approved by, the 
Institutional Review Board of UFRGS.
Results
Sample
UFRGS’s Laboratory of Oral Pathology received a 
total of 1195 lip biopsy specimens from 1946 through 
2011; all were included in this study. Overall analysis 
showed that 44 histopathological lesion types were 
recorded. Table 1 shows the distribution of lesions 
within groups according to anatomic location, and 
patients’ sex and age.
Frequency and demographic distribution
A slight majority (53%) of lesion samples 
were from women. The average patient age was 
36.2 years (standard deviation, 20.6 years; range, 
3 months–96 years). In the first two decades of life, 
lesions were more prevalent in women; thereafter, 
the distribution of lesions did not differ according 
to sex. The majority of lesions (n = 840, 70.4%) were 
from white individuals. The majority (n = 699, 
58.6%) of lesions were reactive, followed by benign 
neoplasms (n = 238, 19.9%), disorders of epithelial 
maturation (n = 138, 11.5%), malignant neoplasms 
(n = 56, 4.7%), others (n = 35, 2.9%), infectious 
lesions (n = 20, 1.7%), and autoimmune diseases 
(n = 9, 0.7%; Table 1). The most prevalent reactive 
lesions were oral mucoceles (n = 453, 37.9%) and 
those characterized by inflammatory hyperplasia 
(n = 167, 14%). The most common benign neoplasms 
were fibromas (n = 108, 9%), papillomas (n = 51, 
4.3%), and hemangiomas (n = 36, 3%). Forty-seven 
(3.9%) malignant neoplasms were diagnosed as 
oral squamous cell carcinoma (Table 1). Figure 1 
shows the distribution of lesions according to 
histopathological type and age group.
The most common lesion location was the lower 
lip (n = 915, 76.6%), followed by the upper lip (n = 134, 
11.2%) and the commissure (n = 70, 5.8%). On the 
lower lip, 49.1% (n = 587) of lesions were reactive, 
followed by benign neoplasms (n = 151, 12.6%). The 
same pattern was observed for the upper lip (reactive 
lesions: n = 62, 5.2%; benign neoplasms: n = 39, 3.3%). 
Fibromas were the most prevalent lesions on the 
commissure (n = 19, 1.6%; Table 1).
Seventy-seven (8.3%) cases were diagnosed as 
malignant or PMD lesions, based on histopathological 
analysis. The majority of patients diagnosed with 
malignant lesions were in their fourth (20.4%) and 
fifth (32%) decades of life (Figure 2). The lower lip 
was the predominant site of PMD (n = 36, 76.6%) and 
malignant (n = 43, 76.8%) lesions.
Sensitivity of clinical diagnosis for all lesions
Sensitivity values for all lesion groups are 
presented in Table 2. For this analysis, we treated 
all cases of missed clinical diagnosis under the 
assumption that the clinicians who performed the 
biopsies had no diagnostic hypothesis. Sensitivity 
values were greatest for autoimmune and reactive 
lesions (77% and 72%, respectively). Table 3 shows 
the distribution of clinical diagnostic hypotheses 
and final histopathological diagnoses stratified 
by malignant, PMD, and non-malignant lesions. 
No clinical diagnosis was recorded for 185 (15.5%) 
cases, and two diagnostic hypotheses (differential 
diagnosis) were recorded for 18 (1.5%) cases. After the 
exclusion of cases with descriptive histopathological 
diagnoses and those with no clinical diagnostic 
hypothesis, the concordance between the provisional 
and final diagnoses was calculated: these values 
were 88.3% for PMD and malignant lesions and 
98.2% for non-malignant lesions (p < 0.001; Table 4).
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Table 1. Histopathological distribution of lip lesions according to gender, age and affected site (n = 1195).
Groups n (%)
Gender n (%) Site n (%)
NI, (n%)
Male Female Lower Lip Upper Lip Comissure
G1
Epithelial hyperplasia 40 (3.3) 12 (1) 28 (2.3) 28 (2.3) 3 (0.2) 5 (0.4) 4 (0.3)
Actinic Cheilitis 38 (3.2) 28 (2.3) 10 (0.8) 31 (2.6) 2 (0.2) 1 (0.1) 4 (0.3)
Hyperkeratosis 26 (2.2) 22 (1.8) 4 (0.3) 9 (0.7) 13 (1.1) 2 (0.2) 2 (0.2)
Acantosis + Hyperkeratosis 22 (1.8) 17 (1.4) 5 (0.4)  13 (1.1) 3 (0.2) 5 (0.4) 1 (0.1)
Epithelial dysplasia 9 (0.7) 8 (0.7) 1 (0.1) 5 (0.4) 2 (0.2) 1 (0.1) 1 (0.1)
Hyperkeratosis + Melanosis 2 (0.2) 1 (0.1) 1 (0.1) 2 (0.2) - - -
Cutaneous Horn 1 (0.1) 1 (0.1) - - - 1 (0.1) -
Total 138 (11.5) 89 (7.4) 49 (4.1) 88 (7.4) 23 (1.9) 15 (1.2) 12 (1)
G2
Lichen planus 6 (0.5) - 6 (0.5) - 2 (0.2) 1 (0.1) 3 (0.2)
Penfigus vulgaris 2 (0.2) 1 (0.1) 1 (0.1) 2 (0.2) - - -
Sjögren Syndrome 1 (0.1) 1 (0.1) - 1 (0.1) - - -
Total 9 (0.7) 2 (0.2) 7 (0.6) 3 (0.2) 2 (0.2) 1 (0.1) 3 (0.2)
G3
Mucocele 453 (37.9) 221 (18.5)  232 (19.4) 433 (36.2) 14 (1.2) 3 (0.2) 3 (0.2)
Inflamatory hyperplasia 167 (14) 54 (4.5) 113 (9.4) 120 (10) 37 (3.1) 7 (0.6) 3 (0.2)
Pyogenic granuloma 33 (2.8) 14 (1.2) 19 (1.6) 23 (1.9) 8 (0.7) 1 (0.1) 1 (0.1)
Cronic inflamation 24 (2) 8 (0.7) 16 (1.3) 3 (0.2) - 10 (0.8) 11 (0.9)
Fibrosis 7 (0.6) 3 (0.2) 4 (0.3) - - - 7 (0.6)
Foreign body reaction 4 (0.3) 1 (0.1) 3 (0.2) 1 (0.1) 1 (0.1) 1 (0.1) 1 (0.1)
Melanosis 3 (0.2) 2 (0.2) 1 (0.1) 2 (0.2) - - 1 (0.1)
Traumatic Ulcer 3 (0.2) 2 (0.2) 1 (0.1) 2 (0.2) 1 (0.1) - -
Giant cell lesion 2 (0.2) - 2 (0.2) 1 (0.1) - - 1 (0.1)
Papilomatosis 1 (0.1) - 1 (0.1) 1 (0.1) - - -
Keloid 1 (0.1) 1 (0.1) - 1 (0.1) - - -
Necrosis 1 (0.1) - 1 (0.1) - 1 (0.1) - -
Total 699 (58.6) 306 (25.7) 393 (32.9) 587 (49.1) 62 (5.2) 22 (1.8) 28 (2.2)
G4
Paracoccidioidomicosis 14 (1.2) 13 (1.1) 1 (0.1) 14 (1.2) - - -
Molluscum Contagiosum 2 (0.2) - 2 (0.2) 2 (0.2) - - -
Verruga vulgaris 2 (0.2) 1 (0.1) 1 (0.1) 2 (0.2) - - -
Actynomicosis 1 (0.1) 1 (0.1) - 1 (0.1) - - -
Leucoplastic Candida 1 (0.1) - 1 (0.1) - 1 (0.1) - -
Total 20 (1.7) 15 (1.2) 5 (0.4) 19 (1.6) 1 (0.1) - -
G5
Fibroma 108 (9) 34 (2.8) 74 (6.2) 75 (6.3) 9 (0.7) 19 (1.6) 5 (0.4)
Papilloma  51 (4.3) 25 (2.1) 26 (2.2) 33 (2.8) 6 (0.5) - 12 (1)
Hemangioma 36 (3) 11 (0.9) 25 (2.1) 21 (1.7) 10 (0.8) 5 (0.4) -
Lipoma 12 (1) 5 (0.4) 7 (0.6) 7 (0.6) 5 (0.4) - -
Pleomorphic adenoma 9 (0.7) 3 (0.2) 6 (0.5) 7 (0.6) 1 (0.1) 1 (0.1) -
Traumatic Neuroma 8 (0.7) 2 (0.2) 6 (0.5) - 6 (0.5) 2 (0.2) -
Keratoacanthoma 6 (0.5) 3 (0.2) 3 (0.2) 6 (0.5) - - -
Schwannoma 4 (0.3) 1 (0.1) 3 (0.2) - - - 4 (0.3)
Lymphangioma 3 (0.2) 3 (0.2) - 2 (0.2) 1 (0.1) - -
Angiomioma 1 (0.1) 1 (0.1) - - 1 (0.1) - -
Total 238 (19.9) 88 (7.4) 150 (12.5) 151 (12.6) 39 (3.3) 27 (2.2) 21 (1.7)
Continue
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Accuracy of clinical examination for 
diagnosis of PMD and malignant lip lesions
In the analysis of whether initial clinical 
screening was accurate for PMD and malignant 
lesions, we excluded cases with descript ive 
histopathological diagnoses and those with 
missing cl in ical diagnoses. The sensit ivity 
(88.3%), specificity (98.2%), and accuracy (97.4%) 
of clinical diagnoses of PMD and malignant lesions 
combined, obtained by comparing provisional 
clinical diagnoses with final histopathological 
diagnoses, were excellent (Table 5).
Discussion
This study is the first to assess the accuracy 
of clinical diagnoses of PMD and malignant lip 
lesions. It is also the largest epidemiological study 
to date of clinical and histopathological data from 
benign and malignant lip lesions. Our sample was 
composed of a wide range of lesions with different 
etiologies; lesions were predominantly reactive and 
inflammatory. Clinical diagnosis of autoimmune and 
reactive lesions showed a high degree of sensitivity. 
More importantly, clinical examination showed a 
high degree of accuracy and high predictive value 
Continuation
G6
Squamous cell carcinoma 47 (3.9) 41 (3.4) 6 (0.5) 40 (3.3) 2 (0.1) 3 (0.2) 2 (0.1)
Verrucous carcinoma 6 (0.5) 6 (0.5) - 3 (0.2) - - 3 (0.2)
Basocellular carcinoma 2 (0.2) 1 (0.1) 1 (0.1) - 2 (0.1) - -
Multiple endocrin neoplasia 1 (0.1) - 1 (0.1) - 1 (0.1) - -
Total 56 (4.7) 48 (4) 8 (0.7) 43 (3.6) 5 (0.4) 3 (0.2) 5 (0.4)
G7
Benign Melanocitic Lesion 12 (1) 4 (0.3) 8 (0.6) 4 (0.3) - 1 (0.1) 7 (0.6)
Chronic Sialoadenitis 12 (1) 5 (0.4) 7 (0.6) 12 (1) - - -
Cystic Lesion 11 (0.9) 6 (0.5) 5 (0.4) 8 (0.7) 2 (0.2) 1 (0.1) -
Total 35 (2.9) 15 (1.2) 20 (1.7) 24 (2) 2 (0.2) 2 (0.2) 7 (0.6)
TOTAL 1195 (100) 563 (47.1) 632 (52.9) 915 (76.6) 134 (11.2) 70 (5.8) 76 (6.3)
NI indicates not informed.








G1 - Disorders of epithelial maturation
G2 - Autoimmune lesions
G3 - Reactive lesions
G4 - Infectious lesions
G5 - Benign neoplasms
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for the diagnosis of PMD and malignant lip lesions. 
These findings strengthen the evidence supporting 
immediate biopsy and histopathological examination 
in cases of suspected malignancy. Conversely, they 
suggest that follow up is sufficient for cases with no 
suspected malignancy. Although these results are 
promising, they should be interpreted with caution, 
given the biases inherent to this cross-sectional 
retrospective study (e.g., population selection, high 
degree of interexaminer variability).
Regardless of  anatomic reg ion,  c l in ica l 
examination is usually not sufficient for accurate 
diagnosis; histopathological examination is essential 
for appropriate clinical decision making.22,23 Several 
studies15,17,18 of oral lesions have been based only on 
clinical data, with no report of histopathological 
characteristics. Microscopic evaluation is understood 
to be required to establish the final diagnosis and, 
thus, the appropriate treatment in all cases of PMD 
and malignant lesions.19,20 In many clinical cases, 
the lines dividing diagnoses of benign, PMD, and 
malignant lesions are very thin; clinicians face the 
challenges of formulating diagnostic hypotheses 
and predicting which PMD lesions will progress to 
malignancy.33 A recent systematic review assessed 
the diagnostic accuracy of adjunctive tests combined 
with oral examination for oral cancer; due to 
the overall poor quality of studies included, the 
authors failed to identify a replacement for biopsy 
and histological assessment for final diagnosis.34 
However, the accuracy of initial clinical assessment 
of lip lesions observed in this study suggests that 
this type of examination alone can be reliable. The 
study results further suggest that periodic follow 
up is appropriate in cases with no suspicion of 
malignancy. These findings are very valuable, 
given that initial examination is performed at the 
primary care level in various scenarios.35,36 These 
findings, however, should be interpreted with 
caution, as many factors, such as training and 
Table 2. Sensitivity test values for clinical examination 
and diagnosis of lip lesions according to groups of 
histopathological diagnoses.
Groups Sensitivity
G1 – Epithelial disorders 0.42
G2 – Autoimmune lesions 0.77
G3 – Reactive lesions 0.72
G4 – Infectious lesions 0.40
G5 – Benign neoplasms 0.55
G6 – Malignant lesions 0.57
G7 – Others 0.34
Total 0.62




Malignant lesion Potentially malignant disorder Non-malignant lesion Descriptive
Malignant lesion 30 (53.6%) 2 (5.3%) 11 (1.1%) 4 (3.8%) 47 (3.9%)
Potentially malignant disorder 4 (7.1%) 22 (57.9%) 4 (0.4%) 37 (35.2%) 67 (5.6%)
Non-malignant lesion 5 (8.9%) 4 (10.5%) 834 (83.7%) 35 (33.4%) 878 (73.5%)
Differential diagnosis* 7 (12.5%) 3 (7.9%) 6 (0.6%) 2 (1.9%) 18 (1.5%)
No clinical diagnosis 10 (17.9%) 7 (18.4%) 141 (14.2%) 27 (25.7%) 185 (15.5%)
Total 56 (100%) 38 (100%) 996 (100%) 105 (100%) 1195 (100%)
*18 cases of differential diagnosis between a malignant or potentially malignant lesion and a non-malignant lesion.
Figure 2. Distribution of potentially malignant and malignant 
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Malignant or potentially malignant lesion Non-malignant lesion
Malignant or potentially malignant lesion 68 15 83
Non-malignant lesion 9 840 849
Total 77 855 932
Fisher’s exact test, p <.001.
Table 5. Accuracy, predictive value, sensitivity and specificity of clinical examination for PMD and malignant lesions in the lips.
Variable Estimate
95% Confidence interval
Lower limit Upper limit
Disease occurrence 8.3 % 6.6 % 10.2 %
Sensitivity 88.3 % 79.1 % 94.5 %
Specificity 98.2 % 97.1 % 99.1 %
Positive likelihood ratio 50.3 30.28 83.67
Negative likelihood ratio 0.12 0.06 0.22
Positive predictive value 81.9 % 71.9 % 89.5 %
Negative predictive value 98.9 % 98.0 % 99.5 %
Accuracy 97.4%  -  -
experience, can affect clinicians’ decision making 
in individual settings.37 These factors were not 
considered in this study.
Cancerous lip lesions are often preceded by 
noticeable changes in the oral or lip mucosa, also 
known as PMD; this process allows clinicians to 
detect and effectively treat lesions in the early stages 
of oral carcinogenesis.38 The high degree of accuracy 
and high positive and negative predictive values 
(81.9% and 98.9%, respectively) for clinical diagnosis 
of PMD and malignant lip lesions in this study 
reflect clinicians’ ability to discern the nature of 
these cases correctly. The overall accuracy and 
sensitivity of clinical diagnosis found in this study 
are greater than reported in previous studies,20,26 but 
this difference must be interpreted with caution, 
given that our sample included only lip lesions. 
On the other hand, the sensitivity of clinical diagnosis 
of malignant lesions and disorders of epithelial 
maturation separately was lower (57% and 52%, 
respectively). Final histopathological diagnoses 
were classified as missing in more than 100 cases 
due to missing information about lesion location 
and characteristics or failure to follow standard 
recommendations for biopsy. This has been reported 
previously,21 and, we stress the importance of a good 
standard biopsy procedure for histological assessment 
to avoid incomplete diagnosis and/or misdiagnosis.
This study adds to the body of evidence regarding 
the distribution of lip pathologies in all age groups. 
Two previous studies assessed the frequency of lip 
lesions using histopathological data.14,39 A study 
conducted in Brazil14 involved the retrospective 
analysis of clinical and histopathological data from 
1034 lip lesions diagnosed over a 5-year period in 
five pathology centers. The authors reported no sex 
predilection and an age range encompassing the 
first through the ninth decades of life. Most (59.5%) 
lesions were reactive or inflammatory, followed by 
malignant (21.7%) and benign (19.1%) tumors. The 
most common lip lesion was mucocele (28.4%), and the 
lower lip was the most commonly affected region.14 
Our results corroborate these findings with respect 
to the absence of sex predilection, the wide age range, 
and the predominance of mucocele and lower lip 
location. Although we also found that reactive lesions 
were most common, they were followed in occurrence 
frequency by benign tumors and disorders of epithelial 
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maturation. Other authors have described similar 
clinical findings,15,39,40 but the studies are marked by 
important methodological variations (e.g., sample 
size, inclusion of only benign lesions).
The present findings are derived from the analysis 
of records collected over a 65-year period in an 
oral pathology diagnostic service, which receives 
specimens from the public health system and private 
practitioners, as well as from students supervised by 
oral pathologists and oral surgeons. We could not 
assess exposure to risk factors, such as tobacco use, 
alcohol consumption, and UV radiation, as patient 
records contained no such information in most 
older cases. Furthermore, we lacked information 
about biopsy type. Nevertheless, as oral lesions are 
usually small, excisional biopsy is performed as 
definitive treatment in most cases.22 In addition, data 
on the year of sample collection and analysis were 
not accessible. An important factor that should be 
taken into account is that much has changed in the 
diagnostic sciences over the study period, creating 
a potential source of bias.
In this retrospective analysis of data from 
a representative population with lip lesions, 
we calculated the specificity and sensitivity of 
clinical examination of lip lesions. Considering 
the cross-sectional and retrospective nature of 
this study, we emphasize the need for large-
scale prospective studies with consecutive subject 
recruitment to further examine the accuracy of the 
clinical diagnosis of oral lesions.
Conclusion
Clinical examination of the lips showed a high 
degree of accuracy for the detection of PMD and 
malignant lesions, indicating good reliability.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. 
CA Cancer J Clin 2016;66(1):7-30. doi:10.3322/caac.21332
2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers 
C, Rebelo M et al. Cancer incidence and mortality 
worldwide: sources, methods and major patterns in 
GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86. 
doi:10.1002/ijc.29210
3. Boing AF, Peres MA, Antunes JL. Mortality from oral and 
pharyngeal cancer in Brazil: trends and regional patterns, 
1979-2002. Rev Panam Salud Publica. 2006;20(1):1-8. 
doi:10.1590/S1020-49892006000700001
4. Warnakulasuriya S. Living with oral cancer: 
epidemiology with particular reference 
to prevalence and life-style changes that 
influence survival. Oral Oncol. 2010;46(6):407-10. 
doi:10.1016/j.oraloncology.2010.02.015
5. Carvalho AL, Nishimoto IN, Califano JA, Kowalski 
LP. Trends in incidence and prognosis for head and 
neck cancer in the United States: a site-specific analysis 
of the SEER database. Int J Cancer. 2005;114(5):806-16. 
doi:10.1002/ijc.20740
6. Howlader NNA, Krapcho M, Garshell J, Miller D, 
Altekruse SF, Kosary CL et al., editors. SEER cancer 
statistics review, 1975-2013. Bethesda, MD: National 
Cancer Institute; 2015. p. 1975-2012.
7. Visscher JG, Waal I. Etiology of cancer of the lip: 
a review. Int J Oral Maxillofac Surg. 1998;27(3):199-203. 
doi:10.1016/S0901-5027(98)80010-6
8. Håkansson N, Floderus B, Gustavsson P, 
Feychting M, Hallin N. Occupational sunlight 
exposure and cancer incidence among Swedish 
construction workers. Epidemiology. 2001;12(5):552-7. 
doi:10.1097/00001648-200109000-00015
9. Spitzer WO, Hill GB, Chambers LW, Helliwell BE, 
Murphy HB. The occupation of fishing as a risk factor 
in cancer of the lip. N Engl J Med. 1975;293(9):419-24. 
doi:10.1056/NEJM197508282930903
10. Cancer Research UK. Oral cancer incidence statistics. 
London: Cancer Research UK; 2015 [cited 2015 Sep]. 
Available from: http://www.cancerresearchuk.org/ 
health-professional/cancer-statistics/ 
statistics-by-cancer-type/oral-cancer/incidence
11. Sargeran K, Murtomaa H, Safavi SM, Vehkalahti MM, 
Teronen O. Survival after lip cancer diagnosis. J Craniofac 
Surg. 2009;20(1):248-52. doi:10.1097/SCS.0b013e31818431bd
12. Moore S, Johnson N, Pierce A, Wilson D. The 
epidemiology of lip cancer: a review of global 
incidence and aetiology. Oral Dis 1999;5(3):185-95. 
doi:10.1111/j.1601-0825.1999.tb00300.x
13. Neville BW, Day TA. Oral cancer and precancerous 
lesions. CA Cancer J Clin. 2002;52(4):195-215. 
doi:10.3322/canjclin.52.4.195
14. Osterne RL, Costa FW, Mota MR, Vidal Patrocínio RM, 
Alves AP, Soares EC et al. Lip lesions in a Brazilian 
population. J Craniofac Surg. 2011;22(6):2421-5. 
doi:10.1097/SCS.0b013e318232a7dc
References
8 Braz. Oral Res. 2016;30(1):e135
Curra M, Salvadori G, Junges R, Sant’Ana Filho M, Hugo FN, Martins MD
15. Patil S, Maheshwari S. Prevalence of lip lesions in an 
Indian population. J Clin Exp Dent. 2014;6(4):e374-8. 
doi:10.4317/jced.51597
16. Rathod S, Livergant J, Klein J, Witterick I, Ringash 
J. A systematic review of quality of life in head and 
neck cancer treated with surgery with or without 
adjuvant treatment. Oral Oncol. 2015;51(10):888-900. 
doi:10.1016/j.oraloncology.2015.07.002
17. Lingen MW, Kalmar JR, Karrison T, Speight PM. 
Critical evaluation of diagnostic aids for the 
detection of oral cancer. Oral Oncol. 2008;44(1):10-22. 
doi:10.1016/j.oraloncology.2007.06.011
18. Bouquot JE. Common oral lesions found during a mass 
screening examination. J Am Dent Assoc. 1986;112(1):50-7. 
doi:10.14219/jada.archive.1986.0007
19. Güneri P, Epstein JB. Late stage diagnosis of oral 
cancer: components and possible solutions. Oral Oncol. 
2014;50(12):1131-6. doi:10.1016/j.oraloncology.2014.09.005
20. Onofre MA, Sposto MR, Navarro CM, Motta ME, 
Turatti E, Almeida RT et al. Potentially malignant 
epithelial oral lesions: discrepancies between clinical 
and histological diagnosis. Oral Dis. 1997;3(3):148-52. 
doi:10.1111/j.1601-0825.1997.tb00026.x
21. Pentenero M, Carrozzo M, Pagano M, Galliano D, 
Broccoletti R, Scully C et al. Oral mucosal dysplastic 
lesions and early squamous cell carcinomas: 
underdiagnosis from incisional biopsy. Oral Dis. 
2003;9(2):68-72. doi:10.1034/j.1601-0825.2003.02875.x
22. Oliver RJ, Sloan P, Pemberton MN. Oral biopsies: 
methods and applications. Br Dent J. 2004;196(6):329-33. 
doi:10.1038/sj.bdj.4811075
23. Mota-Ramírez A, Silvestre FJ, Simó JM. Oral biopsy in dental 
practice. Med Oral Patol Oral Cir Bucal. 2007;12(7):E504-10.
24. Patel KJ, De Silva HL, Tong DC, Love RM. Concordance 
between clinical and histopathologic diagnoses of oral 
mucosal lesions. J Oral Maxillofac Surg. 2011;69(1):125-33. 
doi:10.1016/j.joms.2010.07.075
25. Sardella A, Demarosi F, Lodi G, Canegallo L, Rimondini L, 
Carrassi A. Accuracy of referrals to a specialist oral medicine 
unit by general medical and dental practitioners and the 
educational implications. J Dent Educ. 2007;71(4):487-91.
26. Seoane J, Warnakulasuriya S, Varela-Centelles P, Esparza 
G, Dios PD. Oral cancer: experiences and diagnostic 
abilities elicited by dentists in North-western Spain. Oral 
Dis. 2006;12(5):487-92. doi:10.1111/j.1601-0825.2005.01225.x
27. Williams HK, Hey AA, Browne RM. The use by general 
dental practitioners of an oral pathology diagnostic 
service over a 20-year period: the Birmingham Dental 
Hospital experience. Br Dent J 1997;182(11):424-9. 
doi:10.1038/sj.bdj.4809403
28. Downer MC, Moles DR, Palmer S, Speight PM. 
A systematic review of test performance in screening for 
oral cancer and precancer. Oral Oncol 2004;40(3):264-73. 
doi:10.1016/j.oraloncology.2003.08.013
29. Mathew B, Sankaranarayanan R, Sunilkumar KB, 
Kuruvila B, Pisani P, Nair MK. Reproducibility and 
validity of oral visual inspection by trained health workers 
in the detection of oral precancer and cancer. Br J Cancer 
1997;76(3):390-4. doi:10.1038/bjc.1997.396
30. Warnakulasuriya S, Pindborg JJ. Reliability of oral 
precancer screening by primary health care workers in Sri 
Lanka. Community Dent Health 1990;7(1):73-9.
31. Warnakulasuriya S, Johnson NW, van der 
Waal I. Nomenclature and classification of 
potentially malignant disorders of the oral 
mucosa. J Oral Pathol Med. 2007;36(10):575-80. 
doi:10.1111/j.1600-0714.2007.00582.x
32. De Luca Canto G, Pachêco-Pereira C, Aydinoz S, Major 
PW, Flores-Mir C, Gozal D. Diagnostic capability of 
biological markers in assessment of obstructive sleep 
apnea: a systematic review and meta-analysis. J Clin Sleep 
Med. 2015;11(1):27-36. doi:10.5664/jcsm.4358
33. Scully C. Challenges in predicting which oral mucosal 
potentially malignant disease will progress to neoplasia. 
Oral Dis. 2014;20(1):1-5. doi:10.1111/odi.12208
34. Macey R, Walsh T, Brocklehurst P, Kerr AR, Liu JL, 
Lingen MW et al. Diagnostic tests for oral cancer  
and potentially malignant disorders in patients 
presenting with clinically evident lesions.  
Cochrane Database Syst Rev. 2015;5:CD010276. 
doi:10.1002/14651858.CD010276.pub2.
35. Brocklehurst PR, Baker SR, Speight PM. A qualitative 
study examining the experience of primary care 
dentists in the detection and management of potentially 
malignant lesions. 2. Mechanics of the referral and 
patient communication. Br Dent J. 2010;208(2):E4. 
doi:10.1038/sj.bdj.2010.55
36. Waal I, Bree R, Brakenhoff R, Coebergh JW. Early 
diagnosis in primary oral cancer: is it possible? 
Med Oral Patol Oral Cir Bucal. 2011;16(3):e300-5. 
doi:10.4317/medoral.16.e300
37. Hassona Y, Scully C, Shahin A, Maayta W, Sawair F. 
Factors influencing early detection of oral cancer by 
primary health-care professionals. J Cancer Educ. 
2016;31(2):285-91. doi:10.1007/s13187-015-0823-2
38. Mignogna MD, Fedele S, Lo Russo L, Ruoppo E, 
Lo Muzio L. Costs and effectiveness in the care of 
patients with oral and pharyngeal cancer: analysis 
of a paradox. Eur J Cancer Prev. 2002;11(3):205-8. 
doi:10.1097/00008469-200206000-00002
39. Ntomouchtsis A, Karakinaris G, Poulolpoulos A, 
Kechagias N, Kittikidou K, Tsompanidou C et al. 
Benign lip lesions. A 10-year retrospective study.  
Oral Maxillofac Surg. 2010;14(2):115-8. 
doi:10.1007/s10006-009-0196-y
40. Bouquot JE, Gundlach KK. Odd lips: the prevalence 
of common lip lesions in 23,616 white Americans over 
35 years of age. Quintessence Int. 1987;18(4):277-84.
9Braz. Oral Res. 2016;30(1):e135
